SBCWW
SBC Medical Group Holdings IncPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 0 trimmed or exited.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | ADD | $12.9K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | ADD | $8.7K |
| TORONTO DOMINION BANK | TRIM | $14.0K |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | $9.3K |
| WOLVERINE ASSET MANAGEMENT LLC | ADD | $12.1K |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | $9.2K |
| UBS Group AG | DOUBLED | $484.00 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | $16.3K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $48.9M |
| Next Q | — | — | — | $49.8M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
3 filings · 0 bullish · 1 bearish · 2 neutral- NEUTRAL DEFA14AMay 28, 2026
SBC Medical Group Holdings filed a DEFA14A (additional definitive proxy soliciting materials) in…
Monitor the definitive proxy statement for director nominees and any shareholder proposals. The board reduction and search for a new independent director suggest ongoing governance adjustments but…
- BEARISH 8-KMay 14, 2026
SBC Medical Group reported Q1 2026 revenue of $43.1M (3.3% above the $41.7M consensus) but net…
The 47% earnings decline and 900 bps EBITDA margin compression signal deteriorating profitability despite a modest revenue beat. With a $23M market cap, the stock is highly sensitive to earnings…
- NEUTRAL 8-KApr 22, 2026
SBC Medical Group Holdings Inc. announced the sale of 3,100,000 shares by CEO Dr. Yoshiyuki Aikawa…
Monitor for potential downward pressure on the stock price due to the large secondary offering, and watch for any future insider selling activity by the CEO. The company's lack of proceeds suggests…
All SBCWW filing & press-release reports (3)
- DEFA14A reportMay 28, 2026
- 8-K reportMay 14, 2026
- 8-K reportApr 22, 2026